Logo - springer
Slogan - springer

Medicine - Cardiology & Angiology | Antithrombotic Drug Therapy in Cardiovascular Disease

Antithrombotic Drug Therapy in Cardiovascular Disease

Askari, Arman T., Lincoff, A. Michael (Eds.)

2010, XIII, 475 p.

A product of Humana Press
Available Formats:
eBook
Information

Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.

You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.

After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.

 
$249.00

(net) price for USA

ISBN 978-1-60327-235-3

digitally watermarked, no DRM

Included Format: PDF and EPUB

download immediately after purchase


learn more about Springer eBooks

add to marked items

Hardcover
Information

Hardcover version

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$319.00

(net) price for USA

ISBN 978-1-60327-234-6

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days


add to marked items

Softcover
Information

Softcover (also known as softback) version.

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$319.00

(net) price for USA

ISBN 978-1-62703-797-6

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days


add to marked items

  • Comprehensive overview of the pathophysiology, including the genetics, of arterial and venous thrombosis
  • Detailed, up-to-date data regarding the use of the currently available antithrombotic therapies for commonly-encountered clinical situations in Cardiology
  • Provides rapid access to instructional discussions of various therapies

Substantial morbidity and mortality remains associated with thrombotic events has stimulated the rapid expansion of the available armamentarium to combat pathologic thrombosis. Pathologic thrombosis plays an essential role in the pathogenesis of acute coronary syndromes (ACS), ischemic complications of percutaneous coronary intervention (PCI), venous thromboembolic disease, and embolic complications of arrhythmias and various cardiomyopathies. Written by experts in the field, Antithrombotic Drug Therapy in Cardiovascular Disease carefully examines individual and various combinations of the available antithrombotic regimens including fibrinolytic agents, antiplatelet therapies (aspirin, thieneopyridines, glycoprotein IIb/IIIa inhibitors), and anticogulant therapies (unfractionated heparin, low-molecular-weight heparins, direct thrombin inhibitors, and synthetic factor X inhibitors), non-ST-segment elevation (NSTE) ACS and ST-segment elevation myocardial infarction (STEMI). A detailed overview, Antithrombotic Drug Therapy in Cardiovascular Disease presents the evidence demonstrating the efficacy of available antithrombotic therapies in specific disease states such as atrial fibrillation, cardiomyopathy, valvular heart disease, and heparin-induced thrombocytopenia (HIT).

Content Level » Professional/practitioner

Keywords » Antiplatelet therapies - Antithrombotic therapies - Atrial fibrillation - Deep vein thrombosis - Myocardial infarction - Pulmonary embolism - Thrombosis - Unstable angina - cardiovascular

Related subjects » Cardiology & Angiology - Internal Medicine - Radiology - Surgery

Table of contents / Preface / Sample pages 

Popular Content within this publication 

 

Articles

Read this Book on Springerlink

Services for this book

New Book Alert

Get alerted on new Springer publications in the subject area of Cardiology.